Post Subject #32   Link to webcast https://onlinexperiences.com/scripts/Server.nxp?LASCmd=AI%3A4%3B jondoeuk 04/17/22 06:23:10 PM #31   AI model will be great for diagnosis, chronic NY1972 04/13/22 08:17:11 PM #30   The data model is not biased compared to NY1972 04/13/22 08:11:23 PM #29   I do think AI is overhyped, but not jondoeuk 04/13/22 06:38:44 PM #28   Deep learning is hype. AI is modeling if NY1972 04/13/22 04:42:16 PM #27   PELEUS was designed and trained on validated data jondoeuk 04/11/22 06:05:56 PM #26   bounced off the low from Mar 07 2022 2.7301 G2G 04/06/22 11:23:00 AM #25   It took 40 years for neural network to NY1972 04/05/22 02:25:35 PM #24   5055 - Precise segmentation of growth patterns in jondoeuk 04/04/22 06:33:36 PM #23   The company will host a KOL webcast & jondoeuk 04/04/22 06:18:11 PM #22   ADXS also found numerous frame shift mutations common NY1972 01/25/22 09:48:54 PM #21   No, but the data its trained on is jondoeuk 01/25/22 07:07:22 PM #20   Computer prediction has not worked for ADXS and NY1972 01/24/22 03:11:42 PM #19   PELEUS was designed and trained using TRACERx data. jondoeuk 01/23/22 03:19:54 PM #18   Looking at sitc poster, 2 pts were dosed NY1972 01/20/22 06:11:39 PM #17   New PR https://www.globenewswire.com/news-release/2021/12/09/2349042/0/en/Achill jondoeuk 12/09/21 05:49:35 PM #16   ACHL is making progress while GNCA is running NY1972 11/13/21 09:49:14 PM #15   From the PR: ''The data we presented today jondoeuk 11/12/21 12:41:51 PM #14   SITC posters https://ir.achillestx.com/static-files/72b85326-1980-405e-91f3-cbb5 jondoeuk 11/12/21 11:27:25 AM #13   Slides https://ir.achillestx.com/static-files/d043ce81-400b-4da5-90b0-21e2fe8c8b jondoeuk 11/12/21 11:25:58 AM #12   SITC and corporate update webcast https://edge.media-server.com/mmc/p/hrieccnt jondoeuk 11/11/21 01:02:53 PM #11   What do you think about the tech? jondoeuk 11/08/21 06:46:57 PM #10   What do you think about the tech? Valuation SweatpantKing 10/30/21 11:23:31 PM #9   The company shared initial data from its Material jondoeuk 10/22/21 02:20:11 PM #8   European Society for Gene and Cell Therapy (ESGCT) Congress: jondoeuk 10/01/21 12:29:15 PM #7   The company has enrolled the first US patient jondoeuk 07/01/21 12:28:20 PM #6   The primary objective of the trial is to jondoeuk 06/22/21 01:22:36 PM #5   The poster https://ir.achillestx.com/static-files/645c95d7-bdbe-438a-9ca2-98b57e jondoeuk 06/04/21 01:16:15 PM #4   ASCO abstract (TIP) https://meetinglibrary.asco.org/record/201330/abstract jondoeuk 05/27/21 12:52:56 PM #3   BofA Securities webcast https://www.veracast.com/webcasts/bofa/hc2021/idmW5F21.c jondoeuk 05/27/21 12:51:42 PM #2   In a case study from the ongoing THETIS jondoeuk 05/14/21 05:04:18 PM #1   This year there will be interim data from jondoeuk 05/14/21 05:01:23 PM Post Subject

© 2022 InvestorsHub.com, Inc.